Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | +1.56% | +4.84% | -2.01% |
May. 14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
May. 13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 177
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Healthcare Insurers
45.6
%
| 19 | 41.6 % | 24 | 45.6 % | +26.40% |
Government
34.3
%
| 18 | 38.8 % | 18 | 34.3 % | +1.78% |
Client
18.9
%
| 8 | 17.4 % | 10 | 18.9 % | +25.49% |
Other
1.2
%
| 1 | 2.1 % | 1 | 1.2 % | -37.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 46 | 100.0 % | 53 | 100.0 % | +15.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Aballi
CEO | Chief Executive Officer | 39 | 22-10-16 |
Kamal Adawi
DFI | Director of Finance/CFO | 45 | 17-05-31 |
Ming-Chou Lee
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Ryan Douglas
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | 22-10-03 | |
John Wegener
SAM | Sales & Marketing | 55 | 13-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Robertson
BRD | Director/Board Member | 61 | 19-07-29 |
Paul Kim
BRD | Director/Board Member | 56 | 23-07-23 |
Wendy Johnson
BRD | Director/Board Member | 72 | 20-09-30 |
Brian Birk
BRD | Director/Board Member | 64 | 08-05-31 |
Franklin Stokes
BRD | Director/Board Member | 54 | 21-06-16 |
Tina Nova
CHM | Chairman | 70 | 19-07-29 |
Ebetuel Pallares
BRD | Director/Board Member | 50 | 12-09-30 |
Ana Hooker
BRD | Director/Board Member | 58 | 21-07-28 |
John Aballi
CEO | Chief Executive Officer | 39 | 22-10-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,373,482 | 8,952,665 ( 51.53 %) | 0 | 51.53 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.01% | 33.88M | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
+1.27% | 26.63B | |
+4.92% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+79.20% | 13.21B | |
+70.11% | 13.08B | |
+40.44% | 12.9B |
- Stock Market
- Equities
- XGN Stock
- Company Exagen Inc.